follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

J&J unit Ethicon withdraws hysterectomy device from market over cancer risk

By

Back to Top Comments Email Print

Latest News

advertisement
Johnson & Johnson world headquarters in New Brunswick.
Johnson & Johnson world headquarters in New Brunswick. - (Johnson & Johnson)

Somerville-based Ethicon on Wednesday issued a letter to hospitals, saying it is voluntarily withdrawing its power morcellator devices from the market.

The devices are used during hysterectomies and the removal of uterine fibroids, but risk spreading undiagnosed cancerous tissue during the procedures, the letter says.

While Ethicon says the devices perform as they are supposed to, it says the risks may outweigh the benefits:

“Because of this uncertainty, Ethicon believes that a market withdrawal of Ethicon Morcellation Devices is the appropriate course of action at this time until further medical guidelines are established and/or new technologies are developed to mitigate the risk.”

The devices’ use was suspended in April, Ethicon said.

Ethicon is a unit of New Brunswick-based Johnson & Johnson.

ALSO ON NJBIZ:

Amazon's 1M sq. ft. Robbinsville fulfillment center ships first order

SMALL-TOWN RETAIL SUCCESS STORIES: In Collingswood, close proximity to big cities is big key

Future of Transportation Trust Fund — 'we're really at a critical point' — is topic of discussion at conference

Share This Story On:
Eric Strauss

Eric Strauss

Eric Strauss is the digital content editor for NJBIZ. He has been a reporter and editor for newspapers in New Jersey and Pennsylvania, as well as for a number of websites. You can contact him at erics@njbiz.com or @acerimrat on Twitter.

advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top